Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses by CNBC Markets | July 9, 2025 7:05 pm | US Markets Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.
